Pneumococcal vaccine conjugate 9-valent - Wyeth

Drug Profile

Pneumococcal vaccine conjugate 9-valent - Wyeth

Alternative Names: PNCRM9; Pneumococcal 9 valent CRM197 vaccine conjugate - Wyeth Vaccines

Latest Information Update: 19 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pneumococcal infections

Most Recent Events

  • 10 Jun 2004 Suspended - Phase-III for Pneumococcal infections in World (IM)
  • 31 Dec 2002 Phase-III clinical trials in Pneumococcal infections in World (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top